Finanzwire Finanzwire
Basculer en Français
9551 Companies
188532 Keywords
120347 Articles
100662 Press releases
Headlines Articles Press releases NX Development Corp Remove
  1. Home
  2. Companies
  3. NX Development Corp
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/21/2024 at 15:05, 1 year 5 months ago

    NX Development Corp. Enrolls First Patient in OVA-302 Study After FDA Orphan Designation for Gleolan(R)

    Gleolan NX Development Corp. OVA-302 Study FDA Orphan Designation
  • PRESS RELEASE

    published on 06/21/2024 at 15:00, 1 year 5 months ago

    NX Development Corp. Enrolls First Patient in OVA-302 Study After FDA Orphan Designation for Gleolan(R)

    NX Development Corp. enrolls first patient in OVA-302 study for cancer management using Gleolan following FDA's Orphan Designation. CEO DeSena and Chairman Kosciessa express excitement for future programs
    Gleolan NX Development Corp. OVA-302 Study Cancer Management Flourescence-guided Surgery
    Logo of NX Development Corp
  • BRIEF

    published on 03/05/2024 at 23:05, 1 year 9 months ago

    NX Development Corp. Awarded Orphan-Drug Designation for Gleolan in Ovarian Cancer Treatment

    FDA NX Development Corp Orphan-Drug Designation Gleolan Ovarian Cancer
  • PRESS RELEASE

    published on 03/05/2024 at 23:00, 1 year 9 months ago

    NX Development Corp. is Granted Orphan-Drug Designation Status by US FDA for Gleolan(R) in Ovarian and Related Cancers

    NX Development Corp. has achieved orphan-drug status from the FDA for Gleolan, aiding in the visualization of ovarian tumors during surgery. The milestone highlights innovation in cancer care and surgery
    FDA Cancer Care Gleolan NX Development Corp. Orphan-drug Status
    Logo of NX Development Corp
Accesswire
  • Published on 12/19/2025 at 01:10, 51 minutes ago

    Ostrom Climate Exits Existing UPRIIS ERPA Arrangements

  • Published on 12/19/2025 at 01:00, 1 hour 1 minute ago

    Sun Peak Metals Announces Completion of Acquisition of Saudi Discovery Company SPV Limited

  • Published on 12/19/2025 at 00:50, 1 hour 11 minutes ago

    High Resolution Gravity Survey Targets Challenger Repeats

  • Published on 12/19/2025 at 00:00, 2 hours 1 minute ago

    LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor

  • Published on 12/18/2025 at 23:10, 2 hours 51 minutes ago

    Air T, Inc. Announces Closing of Regional Express Acquisition

View all ACCESSWIRE
EQS Group
  • Published on 12/18/2025 at 22:05, 3 hours 56 minutes ago

    Abivax to be Added to Nasdaq Biotechnology Index

  • Published on 12/18/2025 at 20:09, 5 hours 51 minutes ago

    EQS-Adhoc: The Grounds Real Estate Development AG: Conversion of the EUR 17 million bond issued in 2023/2024 into a hybrid bond

  • Published on 12/18/2025 at 18:48, 7 hours 13 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 12/18/2025 at 18:01, 7 hours 59 minutes ago

    POS-Transaction in Own Shares

  • Published on 12/18/2025 at 18:00, 8 hours 1 minute ago

    Wicomico County Selects Waga Energy to Upgrade Landfill Gas to RNG in Maryland

View all EQS
Les Echos
  • Published on 12/18/2025 at 18:30, 7 hours 31 minutes ago

    Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV

  • Published on 12/18/2025 at 17:45, 8 hours 16 minutes ago

    Cie du Bois Sauvage : Cancellation of own shares

  • Published on 12/18/2025 at 16:31, 9 hours 30 minutes ago

    In Brazil, ENGIE Fully Commissions Serra do Assuruá, Its Largest Wind Complex Worldwide

  • Published on 12/17/2025 at 20:39, 1 day 5 hours ago

    Aeroports de Paris SA | 2026 Airport charges in Paris

  • Published on 12/17/2025 at 19:30, 1 day 6 hours ago

    Change in the composition of the Board

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2025 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy